Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction.
Clin Infect Dis
; 69(Suppl 5): S408-S411, 2019 10 15.
Article
em En
| MEDLINE
| ID: mdl-31612940
ABSTRACT
With a newly World Health Organization (WHO)-prequalified typhoid conjugate vaccine (TCV), Gavi funding for eligible countries, and a WHO policy recommendation for TCV use, now is the time for countries to introduce TCVs as part of an integrated typhoid control program, particularly in light of the increasing burden of antimicrobial resistance. Continued vaccine development efforts will lead to secure supply of low-cost vaccines, and ongoing vaccine studies will provide critical vaccine performance data and inform optimal deployment strategies, in both routine use and in outbreak settings. TCV programs should include thoughtful communication planning and community engagement to counter vaccine hesitancy.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Febre Tifoide
/
Organização Mundial da Saúde
/
Vacinas Tíficas-Paratíficas
/
Saúde Global
/
Vacinação
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article